Company: CRAC
Filing Date: 2025-07-11
Form Type: S-1/A
Source: 0001213900-25-062977
Chunk: 157

Company: Crown Reserve Acquisition Corp. I
Filing Date: 2025-07-11
Form: S-1/A
Chunk 157
---
. (NASDAQ: PWUP) from August 2023 to June 2024, and Aesther Healthcare Acquisition Corp. (n/k/a Ocean Biomedical, Inc. (NASDAQ: OCEA)) from June 2021 until the completion of its initial business combination in February 2023. Mr. Patel is a seasoned entrepreneur and a registered pharmacist with experience in multiple aspects of the pharmaceutical, biotech and healthcare industries. Mr. Patel also founded and operated Tampa Bay Pharmacy and Apaa LLC, community pharmacies, between 2008 and 2014 and Pharmaceutical Returns of America LLC, a Florida based pharmaceutical reverse distributor, between 2006 and 2010. Mr. Patel has also been a consultant to several return logistics pharmaceutical companies over the years. Mr. Patel possesses an excellent vision to bring transparency, efficiency and cost benefits to US pharmaceutical channel partners. After graduating with a BPharm from University of Nottingham/UK, Mr. Patel completed MSC in Transport, Trade & Finance from Cass Business School, City University, UK. Eric Sherb(age: 38) serves as the Chief Financial Officer and director. He is a CPA with 16 years of experience in accounting advisory, auditing and mergers and acquisitions. Mr.Sherb currently serves as the Chief Financial Officer for SMC Entertainment Inc. (OTC: SMCE), Scienture Holdings, Inc. (NASDAQ: SCNX) and Fatpipe Inc. (NASDAQ: FATN). Mr. Sherb began his career at PricewaterhouseCoopers in New York City in a variety of industries from hedge funds to manufacturing and healthcare (July 2008 to January 2013). Following his time at PricewaterhouseCoopers, Mr. Sherb served as Audit Manager at RBSM LLP (January 2013 to January 2015), and Senior Manager at CFGI (March 2015 to October 2018). Since October 2018, Mr. Sherb has been a founder and owner of EMS Consulting Services, LLC. While he has not previously served as a director, officer or board advisor of a SPAC, Mr. Sherb has extensive experience in financial reporting and governance within the capital markets, including IPOs, direct listings, SPAC and de -SPACtransactions. He has served as chief financial officer and provided financial consultancy services for several NASDAQ and OTC clients, most recently, Scienture Holdings, Inc. (NASDAQ: SCNX). Mr. Sherb has successfully assisted companies with IPO and audit